Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer

OBJECTIVE: While the value of Ki-67 has been recognized in breast cancer, controversy also exists. The goal of this study is to show the prognostic value of Ki-67 according to progesterone receptor (PgR) expression in patients who have estrogen receptor- (ER-) positive, human epidermal growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Young-Joon, Lee, Han-Byoel, Kim, Yun Gyoung, Han, JaiHong, Kim, Yumi, Yoo, Tae-Kyung, Lee, Eun-Shin, Moon, Hyeong-Gon, Noh, Dong-Young, Han, Wonshik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949686/
https://www.ncbi.nlm.nih.gov/pubmed/31975992
http://dx.doi.org/10.1155/2019/7386734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949686/
https://www.ncbi.nlm.nih.gov/pubmed/31975992
http://dx.doi.org/10.1155/2019/7386734

Ejemplares similares